| Company Name: |
ShangHai Biochempartner Co.,Ltd
|
| Tel: |
177-54423994 17754423994 |
| Email: |
2853530910@QQ.com |
| Products Intro: |
Product Name:MERS-CoV-IN-1
CAS:2245697-92-9
Purity:98% HPLC LCMS Package:100mg;500mg;1g
|
| Company Name: |
Jinan Jiuli Biotechnology Co. , Ltd.
|
| Tel: |
15865264761 |
| Email: |
486064515@qq.com |
| Products Intro: |
Product Name:MERS-CoV-IN-1
CAS:2245697-92-9
Purity:98% Package:500mg；1g；5g
|
Benzenamine, 2-[(4-phenoxyphenoxy)methyl]- manufacturers
- MERS-CoV-IN-1
-
- $41.00 / 5mg
-
2025-09-11
- CAS:2245697-92-9
- Min. Order:
- Purity: 99.75%
- Supply Ability: 10g
|
| | Benzenamine, 2-[(4-phenoxyphenoxy)methyl]- Basic information |
| Product Name: | Benzenamine, 2-[(4-phenoxyphenoxy)methyl]- | | Synonyms: | Benzenamine, 2-[(4-phenoxyphenoxy)methyl]-;MERS-CoV-IN-1;MERS-CoV,SARS-CoV,inhibit,coronavirus-induced diseases,SARS,pharmaceutical composition,MERSCoVIN1,excellent,MERS CoV IN 1,SARS coronavirus,Inhibitor,coronavirus;2-((4-Phenoxyphenoxy)methyl)aniline;MERS-CoV-IN-1, 10 mM in DMSO | | CAS: | 2245697-92-9 | | MF: | C19H17NO2 | | MW: | 291.34 | | EINECS: | | | Product Categories: | | | Mol File: | 2245697-92-9.mol | ![Benzenamine, 2-[(4-phenoxyphenoxy)methyl]- Structure](CAS/20210305/GIF/2245697-92-9.gif) |
| | Benzenamine, 2-[(4-phenoxyphenoxy)methyl]- Chemical Properties |
| Boiling point | 463.9±30.0 °C(Predicted) | | density | 1.179±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 250 mg/mL (858.10 mM; Need ultrasonic) | | pka | 3.30±0.10(Predicted) | | form | Solid | | color | White to off-white |
| | Benzenamine, 2-[(4-phenoxyphenoxy)methyl]- Usage And Synthesis |
| Uses | MERS-CoV-IN-1 exhibits excellent inhibitory activity against coronavirus. MERS-CoV-IN-1 is useful as a pharmaceutical composition for preventing coronavirus-induced diseases (MERS-CoV and SARS) (extracted from patent WO2018174442A1, compound 1)[1]. | | Biological Activity | MERS-CoV-IN-1 exhibits excellent inhibitory activity against coronavirus. MERS-CoV-IN-1 is useful as a pharmaceutical composition for preventing coronavirus-induced diseases (MERS-CoV and SARS) (extracted from patent WO2018174442A1, compound 1)[1]. | | References | [1]. Compound for treating diseases caused by coronavirus infection. Patent WO2018174442A1. |
| | Benzenamine, 2-[(4-phenoxyphenoxy)methyl]- Preparation Products And Raw materials |
|